Ken Griffin Angiodynamics Inc Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.51 - $7.84 $31,958 - $45,472	5,800 Added 187.1%	8,900 $69,000
Q2 2024 Aug 14, 2024	SELL	$5.65 - $7.03 $1,130 - $1,406	-200 Reduced 6.06%	3,100 $18,000
Q1 2024 May 15, 2024	BUY	$5.27 - $8.03 $3,688 - $5,621	700 Added 26.92%	3,300 $19,000
Q4 2023 Feb 14, 2024	BUY	$6.17 - $8.04 $11,723 - $15,275	1,900 Added 271.43%	2,600 $20,000
Q3 2023 Nov 14, 2023	SELL	$7.02 - $10.32 $7,020 - $10,320	-1,000 Reduced 58.82%	700 $5,000
Q2 2023 Aug 14, 2023	SELL	$8.29 - $11.16 $35,646 - $47,988	-4,300 Reduced 71.67%	1,700 $17,000
Q1 2023 May 15, 2023	BUY	$9.1 - $15.48 $50,050 - $85,140	5,500 Added 1100.0%	6,000 $62,000
Q4 2022 Feb 14, 2023	BUY	$12.06 - $21.55 $6,030 - $10,775	500 New	500 $6,000

141

32.8M

8.9K

Ticker ANGO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 39,107,800
Market Cap $340M
Description
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.